title: The promotion and marketing of oxycontin: commercial triumph, public health tragedy.
abstract: I focus on issues surrounding the promotion and marketing of controlled drugs and their regulatory oversight. Compared with noncontrolled drugs, controlled drugs, with their potential for abuse and diversion, pose different public health risks when they are overpromoted and highly prescribed. An in-depth analysis of the promotion and marketing of OxyContin illustrates some of the associated issues. Modifications of the promotion and marketing of controlled drugs by the pharmaceutical industry and an enhanced capacity of the Food and Drug Administration to regulate and monitor such promotion can have a positive impact on the public health.
authors.affiliation: Stone Mountain Health Services, St Charles Clinic, St Charles, VA 24282, USA. artvanzee@adelphia.net
authors.forename: Art
authors.initials: A
authors.lastname: Van Zee
mesh_terms: D000701:Analgesics, Opioid; D003132:Commerce; D004345:Drug Industry; D006801:Humans; D040541:Marketing / Q000458:organization & administration; D010098:Oxycodone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010565:Persuasive Communication; D011634:Public Health; D019966:Substance-Related Disorders; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D010098:Oxycodone
references.citation: Arch Intern Med. 2000 Mar 27;160(6):853-60
references.pmid: 10737286
references.citation: J Gen Intern Med. 2002 Mar;17(3):173-9
references.pmid: 11929502
references.citation: South Med J. 2006 Nov;99(11):1245-55
references.pmid: 17195420
references.citation: J Pain Symptom Manage. 2004 Aug;28(2):176-88
references.pmid: 15276196
references.citation: Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27
references.pmid: 16862602
references.citation: Pharmacotherapy. 2002 Jul;22(7):898-904
references.pmid: 12126222
references.citation: Ann Intern Med. 2007 Jan 16;146(2):116-27
references.pmid: 17227935
references.citation: Int J Addict. 1995 Jun;30(8):919-27
references.pmid: 7558484
references.citation: Pain. 1997 Oct;73(1):37-45
references.pmid: 9414055
references.citation: Ann Intern Med. 2007 May 15;146(10):751-2
references.pmid: 17502637
references.citation: Neurology. 2003 Mar 25;60(6):927-34
references.pmid: 12654955
references.citation: Lancet. 1996 Jan 20;347(8995):143-7
references.pmid: 8544547
references.citation: Arch Gen Psychiatry. 1984 Oct;41(10):934-41
references.pmid: 6089692
references.citation: Clin J Pain. 2007 Feb;23(2):173-9
references.pmid: 17237667
references.citation: Clin J Pain. 1999 Sep;15(3):179-83
references.pmid: 10524470
references.citation: J Pain. 2005 Oct;6(10):662-72
references.pmid: 16202959
references.citation: Drug Alcohol Depend. 2006 Feb 1;81(2):103-7
references.pmid: 16023304
references.citation: Clin J Pain. 2007 May;23(4):303-6
references.pmid: 17449990
references.citation: Neurology. 1998 Jun;50(6):1837-41
references.pmid: 9633737
references.citation: Am J Public Health. 2006 Oct;96(10):1755-7
references.pmid: 17008568
references.citation: Clin J Pain. 1997 Jun;13(2):150-5
references.pmid: 9186022
references.citation: Cancer. 1990 Dec 15;66(12):2642-4
references.pmid: 2249204
references.citation: Med Lett Drugs Ther. 2001 Sep 17;43(1113):80-1
references.pmid: 11581580
references.citation: Chest. 1992 Jul;102(1):270-3
references.pmid: 1623766
references.citation: Pain. 1995 Aug;62(2):169-178
references.pmid: 8545142
references.citation: J Pain Symptom Manage. 2002 Apr;23(4):278-91
references.pmid: 11997197
references.citation: Pain. 1990 Dec;43(3):309-318
references.pmid: 2293142
references.citation: J Clin Pharmacol. 2001 May;41(5):500-6
references.pmid: 11361046
references.citation: Anesth Analg. 2003 Oct;97(4):1097-1102
references.pmid: 14500164
references.citation: J Psychosom Res. 1997 Nov;43(5):497-504
references.pmid: 9394266
references.citation: Eur J Pain. 1998;2(3):239-49
references.pmid: 15102384
references.citation: Pain. 1982 Jul;13(3):267-280
references.pmid: 6126853
references.citation: N Engl J Med. 1980 Jan 10;302(2):123
references.pmid: 7350425
references.citation: J Clin Oncol. 1998 Oct;16(10):3230-7
references.pmid: 9779696
references.citation: Spine (Phila Pa 1976). 1998 Dec 1;23(23):2591-600
references.pmid: 9854758
references.citation: J Rheumatol. 1999 Apr;26(4):862-9
references.pmid: 10229408
references.citation: Eur J Pain. 2007 Jul;11(5):490-518
references.pmid: 17070082
references.citation: J Pain Symptom Manage. 1998 Apr;15(4):244-52
references.pmid: 9601160
references.citation: Pain. 2001 Feb 1;90(1-2):47-55
references.pmid: 11166969
references.citation: N Engl J Med. 2003 Mar 27;348(13):1223-32
references.pmid: 12660386
references.citation: N Y Times Web. 2000 Nov 16;:A1, A22
references.pmid: 12159839
references.citation: J Pain Symptom Manage. 2003 Nov;26(5):1026-48
references.pmid: 14585554
references.citation: Neurology. 2002 Oct 8;59(7):1015-21
references.pmid: 12370455
references.citation: J Clin Oncol. 1998 Oct;16(10):3222-9
references.pmid: 9779695
references.citation: Clin J Pain. 1992 Jun;8(2):77-85
references.pmid: 1633386
references.citation: J Rheumatol. 2000 Mar;27(3):764-71
references.pmid: 10743822